Skip to content

Onsite vs. Virtual Group Fitness in Overweight/Obese Women

A Comparison of Onsite vs. Virtual Fitness Program on Anthropometric Measures, Aerobic Fitness, and Vascular Markers of Cardiac Risk Markers in Overweight/Obese Premenopausal Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04974476
Enrollment
35
Registered
2021-07-23
Start date
2021-07-24
Completion date
2021-11-08
Last updated
2021-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Keywords

Exercise Program

Brief summary

The purpose of this study is to compare an onsite to virtual whole-body high intensity interval training (HIIT) program on anthropometric variables, aerobic fitness measures, and vascular markers of cardiac risk in a single study of overweight and obese women.

Interventions

OTHERHIIT Exercise Training

The HIIT total session duration will be approximately 30 minutes and will be composed of 10 sets of 60 seconds of high-intensity exercises, \>80% of maximum heart rate (MHR), interspersed with a recovery period of 60 seconds of low-intensity exercise at 60% of MHR.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 44 Years
Healthy volunteers
No

Inclusion criteria

* Premenopausal adult females over the age of 18 and under the age of 45 with a BMI greater than or equal to 25 and a waist circumference greater than or equal to 35 inches. * No medical contraindications to participation in an exercise program including major medical illnesses (i.e. cardiovascular disease, stroke, cancer, etc.) * Ability to provide informed consent * Willingness and ability to participate in an interval training in-person group fitness exercise program 3x/week for 12 weeks

Exclusion criteria

* Adults unable to consent or mini-mental score less than 18. * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Post-menopausal women * Do not speak English * Prisoners * Subjects on medicines (serum glucose, insulin, weight loss medicines, beta-blockers) and having any medical pre-conditions that would interfere with one's capacity to exercise. * Answer Yes to any of the questions on the Pre-Activity Screening Questionnaire (PASQ)

Design outcomes

Primary

MeasureTime frameDescription
Pulse Wave Velocity (PWV)Up to 12 weeksvascular marker of cardiac risk will be reported as PWV (m/s) as measured using SphygmoCor
Pulse Wave Analysis Augmentation Index (AIx)Up to 12 weeksvascular marker of cardiac risk will be reported as AIx (%) as measured using SphygmoCor
Pulse Wave Analysis Mean Arterial Pressure (MAP)Up to 12 weeksvascular marker of cardiac risk will be reported as MAP (mmHg) as measured using SphygmoCor
Visceral Adipose Tissue (VAT) contentUp to 12 weeksAnthropometric measure will be reported as VAT content as measured by noninvasive direct segmental multi-frequency bioelectrical impedance body composition analyzer
Total AdiposityUp to 12 weeksAnthropometric measure will be reported as Total Adiposity as measured by noninvasive direct segmental multi-frequency bioelectrical impedance body composition analyzer
Aerobic FitnessUp to 12 weeksAerobic Fitness level as measured by the 20 meter shuttle run

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026